Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Machine learning for performance

Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms

Yanlin Mi; Arpit Shukla; Mark Tangney; Sabin Tabirca; Venkata VB Yallapragada

Originally published in Comput Struct Biotechnol J · 2026-06-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Highlights •AI technologies revolutionizing protein design: The review analyzes 4 key AI technologies transforming protein engineering, highlighting their technical implementations, strengths, and limitations.•Commercial breakthroughs across sectors: The review emphasizes the substantial commercial impact of AI in therapeutics, food technology, and industrial biotechnology, showcasing innovations like AI-accelerated vaccine development and next-generation plant-based proteins.•Critical insights into AI-experimental integration: The paper highlights emerging trends such as hybrid physical–AI approaches, which promise to bridge the gap between computational predictions and experimental validation, addressing key challenges in protein design.

Multimodal modeling and regulatory implications

The field is advancing from single-chain protein prediction to multimodal biomolecular modeling. Architectures such as AlphaFold 3 [20] and RoseTTAFold All-Atom [85] enable the simultaneous codesign of proteins, nucleic acids, small-molecule ligands, and posttranslational modifications. These capabilities address critical pharmaceutical bottlenecks in hit-to-lead optimization. Concurrently, the transition of AI-designed biologics into clinical pipelines introduces regulatory challenges. Agencies such as the Food and Drug Administration require strict reproducibility and interpretability. Establishing standardized computational benchmarks and mandated wet-lab validation criteria will be essential to translate in silico predictions into approved therapeutics.

Conclusion

The integration of AI in protein design has begun to fundamentally transformed our ability to engineer proteins with precise specifications and novel functions. This review has highlighted the remarkable progress achieved by applying deep learning, protein language models, and integrated design approaches. These advances have enabled unprecedented achievements across multiple domains, from therapeutic development to environmental applications. The field continues to evolve rapidly, with new methods and applications emerging regularly. The challenges that remain, particularly in areas such as protein dynamics and multiscale integration, depict opportunities for future development. The increasing integration of AI with experimental methods and the emergence of new application areas suggest that the impact of AI on protein design will…

Editorial reading guide

  • What data created and tested the model, and was evaluation independent?
  • What is the cost of a false positive, false negative or out-of-distribution decision?